IAS News and Literature Updates:
November/December 2017
From the President's Desk:
Yuji Matsuzawa
 

There are two important deadlines coming up:
January 15, 2018 – Candidates for the 3rd Antonio M. Gotto, Jr. Prize in Atherosclerosis Research
January 31, 2018 – IAS Visiting Fellowship Awards.
 
The International Atherosclerosis Society is very pleased to announce the 3rd Antonio M. Gotto, Jr. Prize in Atherosclerosis Research which will be presented during the upcoming XVIII International Symposium on Atherosclerosis, June 9-12, 2018 in Toronto, Canada.
The Prize ($ 20,000) is sponsored by Weill Cornell Medical College and the International Atherosclerosis Society.

The IAS continues to mentor and support the future key opinion leaders in the field through a number of initiatives, especially support of early- and mid-career clinicians and researchers. 
The IAS Visiting Fellowship Awards are presented each year in an effort to develop skills that will not only impact favourably on the personal career of the winners but will also enhance clinical and research programs in their home country.

> Complete Article <


Antonio M. Gotto, Jr. Prize in Atherosclerosis Research 
Nomination Deadline: January 15, 2018

The aim of the Gotto Prize is to encourage basic, clinical, and translational research in areas relating to the causes, prevention, and treatment of cardiovascular disease globally. The award recipient will have provided and continues to provide outstanding scientific, medical, or organizational advancement in our ability to understand the causes and to reduce the development of atherosclerosis.

For more information Click Here


 Severe FH Course “IDENTIFYING AND TREATING SEVERE FAMILIAL HYPERCHOLESTEROLEMIA”
(Dubai, UAE, October 14-15, 2017) 

The International Atherosclerosis Society (IAS), the Oman Society of Lipid and Atherosclerosis(OSLA), the Gulf Heart Association (GHA), and the Emirates Cardiac Society (ECS), are happy to make available to our readers some important documents related to the Course on Identifying and Treating Severe Familial Hypercholesterolemia which was held in Dubai, UAE on October 14-15, 2017. The Course was co-chaired by Profs. Raul Santos (President-Elect of IAS), Khalid Al-Rasadi (President, OSLA) and Wael Almahmeed (Board Member of GHA).

Dr. Mutaz Al-Sabah , the president of the Iraqi lipid clinic network established the 7th lipid clinic in the city of Erbil ( 400 km to the north of the capital Baghdad ) at Rizgary teaching hospital in collaboration with the health authority there. This clinic will present diagnostic, therapeutic and research services related to patients who complain from familial lipid disorders (Familial hypercholesterolemia and familial hypertriglyceridemia). Establishing this clinic is part of the IAS-OSLA project in Iraq which was started in 2015. Efforts are made to finalize the infrastructures of the network with the aim of establishing 12 clinics all over Iraq.

The International Atherosclerosis Society (IAS) and Oman Society of Lipid & Atherosclerosis (OSLA) are organizing the Fourth IAS-OSLA Course “Lipid Metabolism and Cardiovascular Risk” to be held in Muscat, Oman, on February 16-19, 2018.
As in 2015, 2016 and 2017, the aim of this Course is to increase the knowledge and experience of early- to mid-career, English-speaking practicing clinicians interested in the management of lipid disorders and will be restricted to 30 clinicians from the Middle East and North Africa (MENA) region who manage patients with lipid disorders.
If you are interested in participating, you must apply before January 7th, 2018. Notifications will be sent by January 12, 2018.
Please send your application to: oslaoman@gmail.com
For more information please click here

Also included in this Newsletter:

XVIII International Symposium on Atherosclerosis
Toronto, Canada
June 9-12, 2018
http://www.isa2018.org/


 Abstract Submission Now Open! 

In the News: 
 
FEATURED COMMENTARIES: 

Mechanism of Dyslipidemia in Diabetes

By: Paul Durrington and Handrean Soran

Recent reviews of diabetic dyslipidemia reveal that lipoprotein metabolism is disturbed both by quantitative changes in factors known to regulate lipoprotein metabolism from studies in other types of dyslipidemia, but also by aberrations which are more specific to diabetes and prediabetes, the significance of which remain unknown or only vaguely comprehended. In this brief review we focus on what we think we know and what we would like to know about the underlying mechanisms producing diabetic dyslipidemia.

> View Complete Commentary <

Understanding the Cellular Cholesterol Economy
By: Andrew J. Brown


“Nothing in biology makes sense except in the light of evolution.” So said the great evolutionary biologist Theodosius Dobzhansky in the early 1970s. In 2010, Douglas Wallace added: “but then nothing in biology exists without energy flux”. And so natural selection and bioenergetics working in tandem helped shape life and its plethora of biological processes, including cholesterol metabolism in humans. Since cholesterol is both lethal and vital, we have evolved elaborate mechanisms to keep our cellular cholesterol levels under tight control

> View Complete Commentary <

UPCOMING MEETINGS:


February 16-19, 2018


The Fourth IAS-OSLA Course
Lipid Metabolism and Cardiovascular Risk
Muscat, Oman



Send Application to: oslaoman@gmail.com
View Meeting Information


February 27 - March 1, 2018

Philippine Lipid and Atherosclerosis Society (PLAS); The 11th APSAVD Congress (2018) Annual Scientific Meeting on Addressing Regional Diversity in Atherosclerosis and Vascular Disease

 Iloilo City, Philippines

View Meeting Information



For a complete listing of all Member Society Meetings and educational activities

Please Click Here

Acknowledgements

The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College.

>> Back To Top <<
 
IAS Newsletter Editors
&
Website Editorial Board
 
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy
Emanuela Folco, PhD
Milan, Italy
Ann Jackson, MBA
Houston, TX, USA

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA

************************************************************************************************************************************************************

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129
Italy

Add us to your address book

Copyright (C) 2017 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile